Word

ALLERGAN AESTHETICS

Status

Registered

Status Code

700

Status Date

Tuesday, January 31, 2023

Serial Number

88821482

Registration Number

6969502

Registration Date

Tuesday, January 31, 2023

Mark Type

4000

Filing Date

Wednesday, March 4, 2020

Published for Opposition

Tuesday, June 30, 2020

Trademark Owner History

Allergan, Inc. - Original Registrant

Classifications

41 Consumer education programs, namely, classes and seminars in the field of medical aesthetics treatments and procedures

5 House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics; anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, namely, anti-inflammatories, anti-infectives, anti-glacuoma pharmaceutical preparations for the treatment of glaucoma, and decongestants; pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels as pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Antibiotics; Antifungal preparations; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, serums, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations; Pharmaceutical preparations for reducing localized fat deposits; Pharmaceutical preparations, namely, processed human donor skin for soft tissue regeneration and reconstruction; processed human donor skin for skin replacement; Non-living biological implants comprised of processed acellular porcine mesh for the surgical repair and reinforcement of soft tissues; Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles

3 House mark used for a line of non-medicated cosmetic and skincare preparations; Skin cleansers; Skin toners; Facial skin lotions; Skin moisturizers; Anti-aging moisturizers; Skin creams and beauty serums; Anti-aging creams; Eye creams and beauty serums; Anti-wrinkle creams; hair texture cream and hair texture lotion; firming creams and lotions as cosmetic preparations; After sun creams; Sun damage repair creams; Age-retardant creams as anti-aging cream; Age spot reducing creams; Sunscreens as a type of sunscreen preparation; Exfoliant creams; Chemical skin peeling solutions as a type of non-medicated skin care preparation; body mist as non-medicated skin care preparation; Body sprays; facial mist as non-medicated skin care preparation; facial spray; Beauty masks; Non-medicated cosmetics in the form of skin and face creams, gels, ointments, pastes, foams, lotions, sprays and waxes for non-medically treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

35 Promoting the public awareness of medical aesthetics treatments and procedures through consumer information programs

44 Providing medical information to consumers and healthcare professionals to enhance their understanding of medical aesthetics treatments and procedures

10 House mark used for a line of surgical, medical, therapeutic and cosmetic instruments for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics, muscle stimulation, body contouring and ophthalmic related diseases and disorders; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; Dermatological microdermabrasion apparatus, namely, instruments used for performing microdermabrasion of the skin and which deliver topical solutions to the skin during a procedure; Cosmetic apparatus, namely, an electronic skin treatment device in the nature of a skin-resurfacing treatment device that combines exfoliation, extraction, and infusion of condition-specific serums to improve skin health, function and appearance; Medical devices, namely, apparatus for tissue cooling, body shaping and contouring, and treatment of cellulite and soft tissue; medical devices used to destroy fat cells; Medical devices, namely, therapeutic apparatus and instruments generating high frequency electromagnetic energy for use in muscle stimulation, treatment of cellulite and soft tissue, and sculpting, shaping and contouring of the body; Medical devices, namely, medical apparatus and instruments generating high frequency electromagnetic energy for use in electrical muscle stimulation for medical purposes, treatment of cellulite, and treatment of soft tissue by means of electrical nerve stimulation for medical purposes; Medical devices to facilitate the placement of cosmetic implants during surgical procedures; Cell transfer apparatus, namely, graft harvesting instruments; medical injectors, namely, adipose tissue and medical fluid injectors; Surgical and medical apparatus and instruments for use in processing adipose tissue; Apparatus for the medical treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely, needles for the injection of hyaluronic acid formulations for medical purposes

"AESTHETICS"

Trademark Events

Jan 31, 2023

Notice Of Registration Confirmation Emailed

Jan 31, 2023

Registered-Principal Register

Dec 28, 2022

Notice Of Acceptance Of Statement Of Use E-Mailed

Dec 27, 2022

Allowed Principal Register - Sou Accepted

Nov 1, 2022

Assigned To Examiner

Oct 12, 2022

Teas/Email Correspondence Entered

Oct 12, 2022

Correspondence Received In Law Office

Oct 12, 2022

Assigned To Lie

Oct 4, 2022

Teas Response To Office Action Received

Apr 4, 2022

Notification Of Non-Final Action E-Mailed

Apr 4, 2022

Non-Final Action E-Mailed

Apr 4, 2022

Su - Non-Final Action - Written

Feb 25, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 24, 2022

Statement Of Use Processing Complete

Feb 16, 2022

Use Amendment Filed

Feb 24, 2022

Sou Extension 3 Granted

Feb 16, 2022

Sou Extension 3 Filed

Feb 24, 2022

Case Assigned To Intent To Use Paralegal

Feb 16, 2022

Teas Extension Received

Feb 16, 2022

Teas Statement Of Use Received

Aug 27, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 25, 2021

Sou Extension 2 Granted

Aug 25, 2021

Sou Extension 2 Filed

Aug 25, 2021

Teas Extension Received

Aug 3, 2021

Teas Change Of Correspondence Received

Aug 3, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 3, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 22, 2021

Teas Change Of Correspondence Received

Feb 27, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 25, 2021

Sou Extension 1 Granted

Feb 25, 2021

Sou Extension 1 Filed

Feb 25, 2021

Teas Extension Received

Aug 25, 2020

Noa E-Mailed - Sou Required From Applicant

Jun 30, 2020

Official Gazette Publication Confirmation E-Mailed

Jun 30, 2020

Published For Opposition

Jun 10, 2020

Notification Of Notice Of Publication E-Mailed

May 26, 2020

Assigned To Lie

May 14, 2020

Approved For Pub - Principal Register

May 13, 2020

Examiner's Amendment Entered

May 13, 2020

Notification Of Examiners Amendment E-Mailed

May 13, 2020

Examiners Amendment E-Mailed

May 13, 2020

Examiners Amendment -Written

May 6, 2020

Examiner's Amendment Entered

May 6, 2020

Notification Of Examiners Amendment E-Mailed

May 6, 2020

Examiners Amendment E-Mailed

May 6, 2020

Examiners Amendment -Written

Apr 29, 2020

Assigned To Examiner

Mar 10, 2020

New Application Office Supplied Data Entered

Mar 7, 2020

New Application Entered